Garrett Wealth Advisory Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-1,485
Closed -$205K – 139
2025
Q4
$205K Buy
+1,485
New +$194K 0.04% 117
2019
Q4
– Sell
-546
Closed -$47.5K – 461
2019
Q3
$47.5K Buy
+546
New +$49K 0.03% 134

Other funds holding NVS

Garrett Wealth Advisory Group's NVS Position: Q1 2026 in Review

Garrett Wealth Advisory Group sold out of Novartis (NVS) in Q1 2026, closing a stake of 1,485 shares — an estimated $205K sold.

Garrett Wealth Advisory Group first reported a position in NVS in Q3 2019 and held it in 2 quarters. The position peaked at $205K in Q4 2025. 1,604 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Garrett Wealth Advisory Group reported no remaining Novartis position as of Q1 2026 after selling out during the quarter.
  • Garrett Wealth Advisory Group sold 1,485 Novartis shares in Q1 2026, an estimated $205K.
  • Garrett Wealth Advisory Group first reported a position in Novartis in Q3 2019 and held it in 2 quarters.
  • Garrett Wealth Advisory Group's Novartis position peaked at $205K in Q4 2025.
  • 1,604 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Garrett Wealth Advisory Group's 13F filing for Q1 2026, filed 27 Apr 2026.